Table 2.
Group/Index | Glycosylated Hemoglobin (HbA1C) | Time Below Range (TBR) | Time in Range (TIR) | Time Above Range (TAR) | Coefficient of Variation of Blood Glucose (CV) | Daily Differences (SD) | Amplitude of Glycemic Excursion (MV) |
---|---|---|---|---|---|---|---|
DN | 8.43±2.90 | 12.47±3.34 | 68.85±21.11 | 28.64±11.68 | 30.61±7.55 | 3.89±1.16 | 5.97±1.13 |
NonDN | 8.53±2.81 | 11.58±3.96 | 72.00±19.81 | 27.30±10.26 | 31.61±8.02 | 3.18±1.05 | 5.18±2.64 |
T/Z | 0.897 | 0.975 | 2.763 | 1.308 | 1.499 | −2.035 | −2.569 |
P | 0.370 | 0.186 | 0.006 | 0.034 | 0.134 | 0.531 | 0.045 |
DR | 8.70±2.00 | 12.36±3.78 | 65.67±21.11 | 29.06±10.78 | 32.23±7.59 | 3.29±1.23 | 5.61±1.58 |
NonDR | 8.26±1.60 | 11.74±2.59 | 76.06±18.21 | 28.05±11.43 | 29.77±7.90 | 3.73±0.99 | 5.14±2.07 |
T/Z | −2.872 | −0.972 | 6.163 | −1.658 | −3.683 | 5.960 | −1.738 |
P | 0.004 | 0.178 | <0.001 | 0.046 | <0.001 | <0.001 | 0.003 |
DPN | 8.74±1.89 | 12.48±4.36 | 64.73±20.40 | 28.98±13.69 | 32.42±7.42 | 7.28±1.17 | 5.69±1.92 |
NonDPN | 8.37±1.82 | 12.03±3.98 | 73.56±8.42 | 26.73±11.58 | 30.38±7.96 | 6.91±1.14 | 5.21±1.96 |
T/Z | −2.241 | −0.565 | 4.974 | −3.983 | −2.976 | −3.611 | 1.031 |
P | 0.026 | 0.688 | <0.001 | <0.001 | 0.003 | <0.001 | 0.036 |
CAD | 8.44±1.95 | 11.96±4.78 | 70.41±20.12 | 27.72±10.54 | 31.16±7.53 | 7.04±1.11 | 5.79±1.08 |
NCAD | 8.69±1.53 | 12.53±3.76 | 69.63±21.74 | 28.10±11.67 | 31.15±8.60 | 7.09±1.29 | 5.28±2.96 |
T/Z | 1.564 | −1.431 | −0.391 | 0.186 | −0.015 | 0.475 | 1.716 |
P | 0.119 | 0.544 | 0.696 | 0.082 | 0.988 | 0.635 | 0.128 |
Notes: Data were expressed as . Items with significant differences, their P-values are indicated in italics.
Abbreviations: DN, diabetic nephropathy; DR, diabetic retinopathy; DPN, diabetic peripheral neuropathy; CAD, carotid artery disease; OR, odds ratio; 95% CI, 95% confidence interval; TIR, time in range.